HealthMap_150x.90_1200.jpg
Rapid National Growth Drives Expansion of Healthmap Solutions Executive Leadership Team with Eric Reimer Appointed Chief Executive Officer
October 01, 2020 12:00 ET | Healthmap Solutions
TAMPA, Fla., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Healthmap Solutions (Healthmap), a growing specialty Population Health Management (PHM) company with an industry-leading Kidney Health Management (KHM)...
HealthMap_150x.90_1200.jpg
Regence and Healthmap Solutions partner to provide Kidney Health Management program to members
June 11, 2020 09:00 ET | Healthmap Solutions
PORTLAND, Ore., June 11, 2020 (GLOBE NEWSWIRE) -- Regence today announced a new partnership with Healthmap Solutions—a growing national Population Health Management company with a flagship Kidney...
American Kidney Fund’s Kidney Kitchen™ Wins 2019 Gold MarCom Award
December 05, 2019 09:30 ET | American Kidney Fund
ROCKVILLE, Md., Dec. 05, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF)’s online Kidney Kitchen™ has won a Gold 2019 MarCom Award in the Digital Media – Website – Nonprofit category. ...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Third Quarter 2019 Financial Results
October 31, 2019 17:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (“Proteon” or the “Company”) (Nasdaq: PRTO), a company that has historically focused on the development of novel,...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics and ArTara Therapeutics Agree to Combine
September 23, 2019 16:20 ET | Proteon Therapeutics, Inc.
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a Syndicate of Healthcare...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Second Quarter 2019 Financial Results
August 07, 2019 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company that has historically focused on the development of novel, first-in-class pharmaceuticals to...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces First Quarter 2019 Financial Results
May 08, 2019 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Review of Potential Strategic Transactions
April 15, 2019 16:30 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
March 28, 2019 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., March 28, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
March 13, 2019 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...